<form id="hpjtn"><span id="hpjtn"><th id="hpjtn"></th></span></form>
      <form id="hpjtn"></form>
        <noframes id="hpjtn"><form id="hpjtn"></form>

        a high-tech pharmaceutical enterprise integrated of R&D, production and sales.

        Hwasun has four workshops and eight production lines for API and formulation products, and has the advantage of Proton Pump Inhibitor API and sustained-release formulation. Main products have been distributed worldwide including EU and Japan. A CEP certificate was granted for Lansoprazole.

        LEARN MORE
        • 15M+
          Cream/Ointment Capacity
        • 150 tons+
          API Capacity
        • 500M+
          Tablet/Capsule Capacity
        • 4
        • 8
          Production Lines
        01 / 01
        • Research and development

          We keep close cooperation with leading universities and CRO companies. With a group of well-qualified technical talents, we develop new products and optimize existing products, and provide sustainable motivation for the company.

          R&D Orientation

          We focus on developing generic API and sustained-release formulation.

          LEARN MORE
        News Info
      1. CompanyNews
      2. IndustryTrends
      3. ExchangeCooperation
      4. MediaCenter
      5. Links